RHYTHM PHARMACEUTICALS, INC. (RYTM) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $12.70M; Long-term Debt, Excluding Current MaturitiesUSD $93.40M; Long-term DebtUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $10.13M; Long-term Debt, Excluding Current MaturitiesUSD $98.34M; Long-term DebtUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $7.30M; Long-term Debt, Excluding Current MaturitiesUSD $100.89M; Long-term DebtUSD (m).
- 2025-09-30: Long-term Debt, Current MaturitiesUSD $5.56M; Long-term Debt, Excluding Current MaturitiesUSD $103.41M; Long-term DebtUSD (m).
RHYTHM PHARMACEUTICALS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD |
|---|---|---|---|
| 2026-06-30 | $12.70M | $93.40M | (m) |
| 2026-03-31 | $10.13M | $98.34M | (m) |
| 2025-12-31 | $7.30M | $100.89M | (m) |
| 2025-09-30 | $5.56M | $103.41M | (m) |
| 2025-06-30 | $3.78M | $106.01M | (m) |
| 2025-03-31 | $1.59M | $107.93M | (m) |
| 2024-12-31 | $1.54M | $108.27M | (m) |
| 2023-12-31 | (m) | $106.14M | (m) |
| 2022-09-30 | (m) | (m) | $72.96M |
| 2022-06-30 | (m) | (m) | $34.27M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |